Advancing Behavioral Interventions Throughout the Life Course

项目总结/摘要 这个R13会议拨款将通过提供一个前沿的论坛来推进行为医学领域。 研究相关的机制驱动的行为干预的行为，并通过支持一个多样化的 有前途的早期研究者（ESI）。行为医学研究院的使命 研究（ABMR），组织举办这次会议，是为了推进行为医学领域 通过创造和传播知识，培养话语，激发变革，最终实现更好的 人人健康。ABMR的成员是杰出的MD和博士科学家，由同行选出， 对行为医学的杰出贡献这次会议的赠款将使ABMR邀请领导人 从不同领域，以加强跨学科的思想交流。2023年年会将在 围绕“在整个生命过程中推进行为干预”的主题组织。的 一个基本的前提是，行为医学领域缺乏一个系统的方法来发展 干预措施。因此，很少有成功的行为干预措施被纳入实践。目标 本次会议的主题将是聚焦应用实验医学方法的研究， 干预发展。通过这种方式，会议计划将传播 美国国立卫生研究院的行为改变科学倡议。会议将于2023年6月8日至11日在 班夫艺术与创意中心，班夫，阿尔伯塔。此R13赠款将支持3个主题演讲的参与 发言人整合了与优先考虑行为干预和创新行为试验相关的问题 方法（目标1）。该计划还将包括围绕数字化等主题组织的5个研讨会， 卫生创新、针对心脏代谢健康不平等的干预措施以及实施科学。 该计划还将举行4次圆桌讨论，解决紧迫的问题，如如何最好地 优先考虑下一个重大的行为试验NIH项目官员将参与会议活动。 将讨论整个生命周期的干预措施。与NIH的下一代计划（ABMR）一致 旨在培养下一代行为医学研究人员的成功。符合本 该R13赠款还将资助2021年设立的ABMR早期研究者（ESI）计划， 现在每年向有潜力成为未来领导者的有前途的ESI提供。将特别注意 招募多元化的ESI群体，包括代表性不足的少数群体（目标2）。除了提供 基金10个ESI出席会议，该奖项将支持为期半天的会前ESI领导 培训，职业发展研讨会，并通过导师计划与ABMR科学家进行1：1的网络交流 (Aim 3）。总之，这R13将传播创新的方法，通过领导者进行行为试验， 该领域，并将促进下一代不同的行为医学研究人员的成功。

Project Summary/Abstract This R13 conference grant will advance the field of behavioral medicine by providing a forum for cutting edge research relevant to the conduct of mechanism-driven behavioral interventions and by supporting a diverse group of promising early-stage investigators (ESIs). The mission of the Academy of Behavioral Medicine Research (ABMR), the organization conducting this conference, is to advance the field of behavioral medicine by creating and disseminating knowledge, cultivating discourse, and inspiring change that culminates in better health for all. The members of ABMR are distinguished MD and PhD scientists, elected by peers for outstanding contributions to behavioral medicine. This conference grant will enable ABMR to invite leaders from diverse fields to enhance the exchange of ideas across disciplines. The 2023 annual meeting will be organized around the theme “Advancing Behavioral Interventions Throughout the Life Course”. The underlying premise is that the field of behavioral medicine has lacked a systematic approach to developing interventions. As a result, few successful behavioral interventions have been integrated into practice. The goal of this conference will be to spotlight research that applies the experimental medicine approach to intervention development. In this manner, the conference program will disseminate the methods promoted by the NIH’s Science of Behavior Change initiative. The meeting will take place from June 8-11, 2023 at the Banff Centre for Arts and Creativity in Banff, Alberta. This R13 grant will support the participation of 3 keynote speakers who integrate issues relevant to prioritizing behavioral interventions and innovating behavioral trial methodologies (Aim 1). The program will also include 5 symposia organized around themes such as digital health innovations, interventions targeting inequities in cardiometabolic health, and implementation science. The program will also feature 4 roundtable discussions that tackle pressing issues such as how best to prioritize the next big behavioral trial. NIH program officials will be integrated into conference activities. Interventions across the lifespan will be discussed. Consistent with the NIH’s Next Generation Initiative, ABMR aims to nurture the success of the next generation of behavioral medicine researchers. Consistent with this goal, this R13 grant will also fund the ABMR Early-Stage Investigator (ESI) Program, established in 2021, and now delivered annually to promising ESIs with potential to become future leaders. Special attention will be paid to recruiting a diverse group of ESIs inclusive of under-represented minorities (Aim 2). In addition to providing funds for 10 ESIs to attend the meeting, this award will support a half-day pre-conference ESI leadership training, a career development workshop, and 1:1 networking with ABMR scientists via a mentorship program (Aim 3). In summary, this R13 will diffuse innovative approaches to conducting behavioral trials via leaders in the field and will promote the success of the next generation of diverse behavioral medicine researchers.